Please assess the completion status of the following clinical trial:

Trial Title: ESCAPE Migraine Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Major Inclusion Criteria:~* Patient must be between the ages of 18 and 70;~* Patient must have a migraine history and demonstrate a refractoriness to medical treatment;~* Patient must have a Patent Foramen Ovale (PFO);~* Patient must be willing and able to give informed consent and complete required follow-up visits.~Major Exclusion Criteria:~* Patient has any medical condition or receives any medication that would preclude participation in the trial~* Patient is enrolled or intends to participate in another clinical study (of an investigational drug or device, new indication for an approved drug or device, or requirement of additional testing beyond standard clinical practice) during the study or within four weeks prior to his/her enrollment in the study.~* Patient is pregnant, or intends to become pregnant during the trial period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Test Arm with Premere investigational (Type: ACTIVE_COMPARATOR): PFO Closure with Premere investigational device.
- Medical management/current medications (Type: ACTIVE_COMPARATOR): Patients in the control group arm will not receive the medical device and will continue medical management.

Based on this trial design, predict the completion outcome and termination type (if applicable).